Inflammation and the redox-sensitive AGE-RAGE pathway as a therapeutic target in Alzheimer's disease

Medicine and Dentistry

• Advanced Glycation End Product Receptor 100%
• Alzheimer's Disease 100%
• Receptor 50%
• Advanced Glycation End-Product 50%
• Glucose Metabolism 25%
• Cytokine 25%
• Chronic Inflammation 25%
• Neurodegeneration 25%
• Microglia 25%
• Amyloid Protein 25%
• Amyloid Plaque 25%
• Immunoglobulin Enhancer Binding Protein 25%
• High Mobility Group B1 Protein 25%
• Translational Protein Modification 25%
• Treatment of Alzheimer's Disease 25%
• S100B 25%

Neuroscience

• Alzheimer's Disease 100%
• Advanced Glycation End Product Receptor 100%
• Advanced Glycation End Product 50%
• Amyloid Protein 50%
• Receptor 50%
• Microglia 25%
• Neurodegeneration 25%
• Metabolic Pathway 25%
• Treatment of Alzheimer's Disease 25%
• Translational Protein Modification 25%
• Immunoglobulin Enhancer Binding Protein 25%
• High Mobility Group B1 Protein 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Inflammation 100%
• Alzheimer's Disease 100%
• Advanced Glycation End Product Receptor 100%
• Receptor 40%
• Advanced Glycation End Product 40%
• Cytokine 20%
• Chronic Inflammation 20%
• Nerve Degeneration 20%
• Amyloid Plaque 20%
• Amyloid Protein 20%
• Immunoglobulin Enhancer Binding Protein 20%
• High Mobility Group B1 Protein 20%